BR112017017805A2 - composição - Google Patents

composição

Info

Publication number
BR112017017805A2
BR112017017805A2 BR112017017805A BR112017017805A BR112017017805A2 BR 112017017805 A2 BR112017017805 A2 BR 112017017805A2 BR 112017017805 A BR112017017805 A BR 112017017805A BR 112017017805 A BR112017017805 A BR 112017017805A BR 112017017805 A2 BR112017017805 A2 BR 112017017805A2
Authority
BR
Brazil
Prior art keywords
microbiota
medium
composition
feces
microbes
Prior art date
Application number
BR112017017805A
Other languages
English (en)
Inventor
Berstad Arnold
Hans Åke Ben Dahlgren Atti-La
Raa Jan
Midtvedt Tore
Original Assignee
Invest Sa Neuchatel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Invest Sa Neuchatel filed Critical Invest Sa Neuchatel
Publication of BR112017017805A2 publication Critical patent/BR112017017805A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/02—Separating microorganisms from their culture media
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

a invenção refere-se a uma composição bioquímica obtida após separação de micróbios e matéria sólida e fibrosa de um ecossistema microbiano (= microbiota), pela remoção dos microrganismos de um meio de cultura em que a microbiota intestinal e/ou fezes foram cultivadas de modo anaeróbico e liberando o meio da microbiota, e o uso da mesma como produto farmacêutico e para o tratamento ou profilaxia de doenças.
BR112017017805A 2015-02-19 2016-02-16 composição BR112017017805A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1550189A SE1550189A1 (en) 2015-02-19 2015-02-19 Therapeutic and prophylactic composition produced by microbiota
PCT/SE2016/050119 WO2016133450A1 (en) 2015-02-19 2016-02-16 Therapeutic and prophylactic composition produced by microbiota

Publications (1)

Publication Number Publication Date
BR112017017805A2 true BR112017017805A2 (pt) 2018-04-10

Family

ID=55646830

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017017805A BR112017017805A2 (pt) 2015-02-19 2016-02-16 composição

Country Status (12)

Country Link
US (1) US20180243350A1 (pt)
EP (1) EP3258947A1 (pt)
JP (1) JP2018511570A (pt)
KR (1) KR20170118828A (pt)
CN (1) CN107249610A (pt)
BR (1) BR112017017805A2 (pt)
CA (1) CA2977217A1 (pt)
IL (1) IL254016A0 (pt)
MX (1) MX2017010710A (pt)
SE (1) SE1550189A1 (pt)
SG (1) SG11201706768PA (pt)
WO (1) WO2016133450A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
AU2011286165B2 (en) 2010-08-04 2016-10-20 Thomas Julius Borody Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
EP3610881A1 (en) 2011-03-09 2020-02-19 Regents Of The University Of Minnesota Compositions and methods for transplantation of colon microbiota
CN108243608A (zh) 2015-05-22 2018-07-03 亚利桑那大学董事会 用于治疗自闭症谱系障碍及相关症状的方法
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071532A1 (en) * 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating chronic fatigue syndrome and related disorders
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11433102B2 (en) 2017-04-05 2022-09-06 Finch Therapeutics Holdings Llc Compositions and methods for treating Parkinson's disease (PD) and related disorders
WO2018187464A1 (en) 2017-04-05 2018-10-11 Crestovo Holdings Llc Compositions and methods for treating diverticulitis and related disorders
CN110996917A (zh) 2017-05-26 2020-04-10 克雷斯顿沃控股公司 包含基于粪便微生物的治疗剂的冻干组合物及其制造和使用方法
WO2018229189A1 (en) * 2017-06-14 2018-12-20 4D Pharma Research Limited Compositions comprising bacterial strains
JP2020530494A (ja) 2017-08-07 2020-10-22 フィンチ セラピューティクス、インコーポレイテッド． 健康な腸バリアを維持及び回復するための組成物及び方法
KR102218992B1 (ko) * 2017-12-12 2021-02-23 한국생명공학연구원 아가토바쿨룸 속 균주를 유효성분으로 함유하는 자폐 범주성 장애의 예방, 개선 또는 치료용 조성물
KR20200118100A (ko) * 2018-02-06 2020-10-14 에벨로 바이오사이언시즈, 인크. 베일로넬라 박테리아를 이용한 암 및 면역 장애를 치료하기 위한 조성물 및 방법
US20200171103A1 (en) * 2018-02-28 2020-06-04 Clinical Research Of Fecal Microbiota Transplantation Japan Corporation Composition containing microorganisms derived from living body and method for manufacturing the same
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
JP2022514145A (ja) 2018-09-27 2022-02-10 フィンチ セラピューティクス ホールディングス エルエルシー てんかんおよび関連する障害を治療するための組成物および方法
KR102340392B1 (ko) * 2018-10-08 2021-12-17 한국생명공학연구원 우울증의 예방 또는 치료 효과를 가지는 장내 미생물 및 이의 용도
CN112852682A (zh) * 2020-08-11 2021-05-28 刘树林 与芽孢杆菌属近缘的厚壁菌门细菌菌株及其抗癌应用
CN113005061A (zh) * 2020-08-11 2021-06-22 刘树林 具有抗癌活性的厚壁菌门细菌菌株及其抗癌用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0916335D0 (en) 2009-09-17 2009-10-28 Martin W J Medicaments
PL2480255T3 (pl) * 2009-09-23 2018-07-31 Thomas Julius Borody Terapia przewlekłych zakażeń jelitowych
WO2011151941A1 (ja) * 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
CA2848762C (en) * 2011-09-14 2021-07-27 Queen's University At Kingston Method for treatment of disorders of the gastrointestinal system
EA201490512A1 (ru) * 2011-10-11 2014-09-30 Ачим Байотерапьютикс Аб Композиции, содержащие культивируемую в анаэробных условиях микробиоту кишечника человека
US20150297642A1 (en) * 2012-11-26 2015-10-22 Thomas Julius Borody Compositions for the restoration of a fecal microbiota and methods for making and using them
EP3107553B1 (en) * 2014-02-18 2021-12-01 Universitätsklinikum Jena Methods and compositions for intestinal microenvironment transfer

Also Published As

Publication number Publication date
US20180243350A1 (en) 2018-08-30
JP2018511570A (ja) 2018-04-26
WO2016133450A1 (en) 2016-08-25
CN107249610A (zh) 2017-10-13
IL254016A0 (en) 2017-10-31
SG11201706768PA (en) 2017-09-28
CA2977217A1 (en) 2016-08-25
SE1550189A1 (en) 2016-08-20
KR20170118828A (ko) 2017-10-25
MX2017010710A (es) 2018-06-07
EP3258947A1 (en) 2017-12-27

Similar Documents

Publication Publication Date Title
BR112017017805A2 (pt) composição
AR106800A1 (es) Composiciones que comprenden cepas bacterianas
CY1122994T1 (el) Μεθοδος καθαρισμου κανναβινοειλων, συνθεσεων και kit αυτων
BR112017011923A2 (pt) bactéria modificada para tratar doenças associadas com hiperamonemia
BR112017004744A2 (pt) corpo vegetal enxertado e método para a produção do mesmo
BR112018015097A2 (pt) composição e reatores
CL2017002650A1 (es) Compuestos novedosos
AR106768A1 (es) Composiciones que comprenden cepas bacterianas
WO2015026235A3 (en) Production of probiotics by in vitro enrichment of beneficial microorganisms from human or animal microbiota
BR112019012354A2 (pt) anticorpos apenas de cadeia pesada anti-bcma
BR112017018327A2 (pt) método para a expressão regulada de um complexo, planta ou célula vegetal, semente, método para modificação de uma sequência, método para alteração da expressão de pelo menos um polinucleotídeo
BR112017001910A2 (pt) uso de bacillus methylotrophicus como estimulante do crescimento vegetal e meio de controle biológico e cepas isoladas desta espécie
GB2551642A (en) Methods and compositions relating to microbial treatment and diagnosis of dis-orders
BR112016015573A2 (pt) Composições e métodos para produção biológica de aminoácidos em micro-organismos hidrogenotróficos
BR112013022761B8 (pt) Compostos moduladores heterocíclicos de síntese de lipídios, suas composições e usos
CO2018001840A2 (es) Composiciones biofarmacéuticas que comprenden anticuerpos anti-il-5
BR112017010311A2 (pt) 4-oxo-3,4-dihidro-1,2,3-benzotriazinas como moduladores de gpr139
CL2020003442A1 (es) Tiofenocarboxamidas sustituidas y análogos de las mismas
PE20142295A1 (es) Composiciones y metodos para el tratamiento de enfermedades y trastornos hepaticos
BR112015025748A2 (pt) construção de dna para imunomodulação, composição farmacêutica, vacina, e uso de uma construção de dna
CL2017000312A1 (es) Elección de microarn como diana para trastornos metabólicos
BR112013020737A2 (pt) grânulo e respectiva composição, métodos para extrair compostos almejados a partir de biomassa, para aglomerar biomassa seca e triturada e para gerar grânulos, processo para extrair um ou mais compostos almejados a partir de biomassa de cultura de suspensão, aparelho para aglomerar cultura de suspensão e dispositivo para avaliar a resistência compressiva de grânulo algáceo e kit
CL2012002902A1 (es) Cepas de bacteriofagos especifica contra bacterias pertenecientes al genero vibrio para la profilaxis y terapia de vibrio anguillarum; y composicion antibacteriana que comprende dicha cepas.
BR112018006276A2 (pt) composto, composição farmacêutica, e, inibidor de subunidade gyrb da dna girase e/ou subunidade pare de topoisomerase iv.
BR112021025116A2 (pt) Células linfocíticas ativadas e métodos de uso das mesmas para tratar câncer e condições infecciosas

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]